BI / Reporting Developer at Azurity Pharmaceuticals

Hyderabad, Telangana, India

Azurity Pharmaceuticals Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

  • Bachelor’s in Computer Science, MIS, or related field
  • Oracle BI or OTBI Certification (Mandatory)
  • At least 1–2 Oracle Cloud BI/reporting implementations with enhancement support
  • 5–6 Years of experience
  • BI Publisher
  • OTBI
  • SQL
  • Excel (Basics & Advanced)
  • Power BI
  • Other BI tools
  • OTBI Subject Areas
  • BI Publisher Layouts
  • Scheduling
  • Bursting Logic
  • Strong Communication
  • Collaboration
  • Product Roadmap Understanding
  • Growth Mindset
  • Ability to Navigate challenges during conversation with Stakeholders

Responsibilities

  • Design and deploy OTBI dashboards and subject areas
  • Build BI Publisher reports (PO Print, Invoice Print, custom KPIs)
  • Configure bursting logic and scheduled reports
  • Work with finance and SCM teams to deliver audit-compliant reports

Skills

OTBI
BI Publisher
SQL
Power BI
Excel
Scheduling
Bursting Logic
OTBI Subject Areas
BI Publisher Layouts

Azurity Pharmaceuticals

Develops specialized formulations of medicines

About Azurity Pharmaceuticals

Azurity Pharmaceuticals develops specialized formulations of existing medicines to meet the needs of patients who are often overlooked by traditional pharmaceutical companies. Their products include oral suspensions and other forms that are easier to administer, particularly for those who have difficulty swallowing pills or need precise dosing. This focus on creating accessible and effective medications enhances patient compliance and addresses gaps in the pharmaceutical market. Azurity serves healthcare providers, hospitals, and pharmacies, generating revenue through the sale of FDA-approved proprietary medicines across various therapeutic areas, including cardiovascular, central nervous system, and oncology. Their goal is to improve patient outcomes by providing high-quality, innovative medicines tailored to specific medical conditions.

Woburn, MassachusettsHeadquarters
2000Year Founded
$182.2MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
401(k) Retirement Plan
Paid Vacation
Paid Holidays
Hybrid Work Options
Professional Development Budget
Tuition Reimbursement
Wellness Program

Risks

Product recalls, like Zenzedi's, can damage brand reputation and cause financial losses.
Integration challenges from Slayback Pharma acquisition may disrupt operations.
Reliance on FDA approvals means regulatory delays could impact product launches.

Differentiation

Azurity focuses on innovative dose forms for overlooked patient needs.
Their FDA-approved products ensure safety and efficacy in specialized formulations.
Azurity's acquisition of Slayback Pharma enhances its development and launch capabilities.

Upsides

Growing demand for personalized medicine aligns with Azurity's specialized dose forms.
Increasing chronic diseases boost need for Azurity's innovative drug delivery systems.
FDA's focus on novel formulations benefits Azurity's product pipeline.

Land your dream remote job 3x faster with AI